Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: efficacy and safety results up to 7 years

BACKGROUND: To report the long-term results of the blinded extension phase of the randomized, controlled study of the combined use of interferon beta-1a (IFN) 30ug IM weekly and glatiramer acetate (GA) 20mg daily compared to each agent alone in relapsing-remitting multiple sclerosis (RRMS). METHODS:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mult Scler Relat Disord
Autores principales: Lublin, Fred D., Cofield, Stacey S., Cutter, Gary R., Gustafson, Tarah, Krieger, Stephen, Narayana, Ponnada A., Nelson, Flavia, Salter, Amber R., Wolinsky, Jerry S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5726798/
https://ncbi.nlm.nih.gov/pubmed/29141831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2017.09.012
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares